Found 21 matching trials
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions PHASE2 The patients are being offered a stem cell transplant. Stem cells are very ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies PHASE2 The purpose of this study is compare the efficacy of haplo-cord transplant ...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Reparixin in Pancreatic Islet Transplantation PHASE2 Inhibition of CXCL8 activity might represent a relevant therapeutic target ...
Show More Location
University Hospital Carl Gustav Carus Dresden
Learn More & Join Trial
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy PHASE2 The purpose of this study is to determine whether the use of lower doses of...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation PHASE2 Background:
Blood stem cells in the bone marrow make all the cells to norm...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Allo HSCT for High Risk Hemoglobinopathies PHASE2 A single center, open label, interventional, phase II trial for donor trans...
Show More Location
Masonic Cancer Center
Learn More & Join Trial
HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis PHASE2 The purpose of this study is to find out whether compared to our standard l...
Show More Location
Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre
Learn More & Join Trial
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies PHASE2 This is a phase II, open-label, prospective study of T cell receptor alpha/...
Show More Location
University of Minnesota Masonic Cancer Center
Learn More & Join Trial